ClinicalTrials.Veeva

Menu

An Artificial Intelligence Algorithm for Identifying Gynecologic Cancer Patients in Need of Outpatient Palliative Care

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Advanced Malignant Female Reproductive System Neoplasm

Treatments

Other: Internet-Based Intervention
Other: Electronic Health Record Review

Study type

Interventional

Funder types

Other

Identifiers

NCT06182332
NCI-2023-09943 (Registry Identifier)
23-008371 (Other Identifier)

Details and patient eligibility

About

This clinical trial tests an artificial intelligence (AI) algorithm for its ability to identify patients who may benefit from a palliative care consult for gynecologic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A significant delay in referral to palliative care often occurs among patients with cancer. This delay can lead to poorer symptom management, decreased quality of life, and care that does not align with patient goals or values. AI algorithms are computer programs that use step-by-step procedures to solve a problem. In this trial, an AI algorithm is applied to patients' medical records in order to identify patients with a high burden of disease. Information gathered from this study may help researchers learn whether this AI algorithm is useful for identifying patients who could benefit from outpatient palliative care consultation.

Full description

PRIMARY OBJECTIVE:

I. To pilot an oncology risk prediction model to identify patients who may benefit from outpatient palliative care consultation to improve symptom management and goal-concordant care in this population.

OUTLINE:

Patients' medical records are reviewed for consideration of palliative care consult using AI algorithm once a week (QW) for 6 months.

Enrollment

221 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patient in Enhanced, Electronic health record (EHR)-facilitated Cancer Symptom Control (E2C2) with a diagnosis of advanced gynecologic malignancy (International Classification of Diseases [ICD] codes C51 through C58)
  • Weekly the reviewers will select patients by looking at patients in sorted order starting with the highest score and proceeding down the list and evaluating each patient for exclusion criteria

Exclusion criteria

  • Patients that have been seen by palliative care will be excluded for 75 days
  • Patients under the age of 18 years
  • Patients currently enrolled with hospice

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

221 participants in 1 patient group

Screening (AI algorithm)
Experimental group
Description:
Patients' medical records are reviewed for consideration of palliative care consult using AI algorithm QW for 6 months.
Treatment:
Other: Electronic Health Record Review
Other: Internet-Based Intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems